Moderna's mission is to deliver the greatest possible impact to people through mRNA medicines. So, what is mRNA? Messenger RNA (mRNA) already exists in your body. It carries a “message” - instructions that direct your cells what to do.

Moderna, Inc. (/ m ə ˈ d ɜːr n ə / mə-DUR-nə) [4] is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines.

We’re making biotech history. Since 2010, we have worked to build the industry's leading mRNA technology platform. Learn more about Moderna’s history.

Mar 26, 2024 · CAMBRIDGE, MA / ACCESSWIRE / March 26, 2024 / Moderna, Inc. (NASDAQ:MRNA) today announced that mRNA-1283, the Company's next-generation COVID-19 vaccine, has successfully met the primary endpoints of its Phase 3 clinical trial, demonstrating a higher immune response against SARS-CoV-2 when compared to mRNA-1273.222, …

Mar 27, 2024 · Moderna is advancing five vaccine candidates against viruses that cause latent infections, all of which are in clinical trials. When latent, a virus is present in the body but exists in a resting state, typically without causing any noticeable symptoms.

Jan 26, 2025 · Moderna, Inc. is a biotechnology company specializing in messenger RNA (mRNA) medicines and is best known for developing one of the first COVID-19 vaccines authorized for emergency use. The drugmaker researches treatments for infectious diseases, cancer, and rare genetic disorders, and is exploring new uses of mRNA technology.

Join us as we deliver the greatest possible impact to people through mRNA medicines. We are on a journey to becoming a real-time AI company, where we embed AI into every aspect of our organization. We know that successful AI implementation means putting our people at the center.

Sep 12, 2024 · Moderna is a leader in the creation of the field of mRNA medicine. Through the advancement of mRNA technology, Moderna is reimagining how medicines are made and transforming how we treat and prevent disease for everyone.

Sep 11, 2023 · Moderna's updated COVID-19 vaccine contains spike proteins for the XBB.1.5 sublineage of SARS-CoV-2 to help prevent COVID-19 in individuals 6 months of age and older. With the U.S. FDA's decision, Moderna will begin shipping doses to vaccination sites across the U.S., with updated vaccines expected to be available in the coming days.

At Moderna, we are grounded in the belief that mRNA is transformational. And, for us, our COVID-19 vaccine Spikevax® is just the beginning. Our mRNA platform, with its speed, scale, and flexibility, is uniquely suited to tackle current and emerging pathogens that threaten global health.